Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10759839
Cell-penetrating peptide
granted -
US 10759833
VMP-like sequences of pathogenic Borrelia species and strains
granted -
US 10759816
Heterocyclic compounds as RSV inhibitors
granted -
US 10759855
Antigen binding molecules to TIGIT
granted -
US 10759906
Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method
granted -
US 10760048
In vitro production of medial ganglionic eminence precursor cells
granted -
US 10760055
Conditionally immortalized long-term stem cells and methods of making and using such cells
granted -
US 10760078
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
granted -
US 10758618
Pharmaceutical compositions comprising meloxicam
granted -
US 10758530
Carboxamide derivatives useful as rsk inhibitors
granted -
US 10758526
Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways
granted -
US 10752599
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
granted -
US 10752581
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
granted -
US 10751428
Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
granted -
US 10752699
Anti-APOBEC3 antibodies and methods of making and using
granted -
US 10752623
Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors
granted -
US 10752882
Compositions and methods for treating retinal diseases
granted -
US 10751419
Method for synthesis of reactive conjugate clusters
granted -
US 10751409
Immunogenic compositions and uses thereof
granted -
US 10751408
Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
granted -
US 10751383
Doses and methods for administering telavancin
granted -
US 10751332
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted -
US 10751317
Methods and compositions for increasing the potency of antifungal agents
granted -
US 10752681
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.